⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

August 28, 2024Clinical and Experimental Dermatology

Efficacy and safety of biotechnological drugs for the treatment of moderate-to-severe psoriasis in the elderly population: a single-center, Italian experience

Filippo Viviani Giorgio Spazzoli Giacomo Clarizio Bianca Maria Piraccini Federico Bardazzi

View Full Paper

Ask AI

Bookmark

Share

Abstract

Demographic changes impose a number of issues regarding the biological treatment of elderly patients with moderate-to-severe psoriasis.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Viviani et al. (2024) studied this question.

synapsesocial.com/papers/68e5aa5ab6db643587544345 https://doi.org/10.1093/ced/llae347

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Biologic Treatment in Elderly Patients with Psoriasis: Focus on Safety and AdherenceOriginal Research · 2026 · 1 citations
2Real‐world safety and efficacy of biologics in elderly patients with psoriasis: A multicenter observational study2024 · 5 citations
3Real-World Use of Biologic Therapy in Elderly Patients with Moderate-to-Severe Psoriasis: A Retrospective Single-Center StudyCohort Study · 2026
4Effectiveness and safety of phototherapy in geriatric psoriasis: a retrospective multicenter studyCohort Study · 2026
5Effectiveness of Guselkumab for the Treatment of Moderate-to- Severe Psoriasis in Elderly Patients: A Retrospective, Real-World Multicenter Study in the Lazio RegionHuman Clinical Trial · 2026